Skip to content
Denton News

Castle Biosciences Announces New York State Department of Health Approval of its AdvanceAD-Tx™ Test

Castle Biosciences Announces New York State Department of Health Approval of its AdvanceAD-Tx™ Test
Photo: Denton Record-Chronicle · view original

Approval expands access to Castle's precision medicine test designed to guide systemic treatment decision making in patients with moderate-to-severe atopic dermatitis

Sources and story details